Jet propellant (JP)-8, the primary jet fuel used by the U.S. military, consists of
hydrocarbon-rich
kerosene base commercial jet fuel (Jet-A) plus additives DC1-4A, Stadis 450 and
diethylene glycol monomethyl ether. Human epidermal keratinocytes (HEK) were exposed to JP-8, aliphatic
hydrocarbon (HC) fuel S-8 and aliphatic HC
pentadecane (
penta),
tetradecane (tetra),
tridecane (tri) and
undecane (un) for 5 min. Additional studies were conducted with signal transduction pathway blockers
parthenolide (P; 3.0 microm),
isohelenin (I; 3.0 microm),
SB 203580 (SB; 13.3 microm),
substance P (SP; 3.0 microm) and recombinant human
IL-10 (rHIL-10; 10 ng ml(-1)). In the absence of inhibitors, JP-8 and to a lesser extent un and S-8, had the greatest toxic effect on cell viability and
inflammation suggesting, as least in vitro, that synthetic
S-8 fuel is less irritating than the currently used JP-8. Each inhibitor significantly (P < 0.05) decreased HEK viability.
DMSO, the vehicle for P, I and SB, had a minimal effect on viability. Overall,
IL-8 production was suppressed at least 30%
after treatment with each inhibitor. Normalizing data relative to control indicate which inhibitors suppress HC-mediated
IL-8 to control levels. P was the most effective inhibitor of
IL-8 release;
IL-8 was significantly decreased after exposure to un, tri, tetra and
penta but significantly increased after JP-8 exposure compared with controls. Inhibitors were not effective in suppressing
IL-8 release in JP-8 exposures to control levels. This study shows that inhibiting
NF-kappa B, which appears to play a role in
cytokine production in HC-exposed HEK in vitro, may reduce the inflammatory effect of HC in vivo.